Sanicle

Sanicle (Sanicula europaea L.): A Comprehensive Reference

1. Identity and Botanical Description

Sanicula europaea, commonly known as sanicle or wood sanicle, is a perennial plant of the family Apiaceae. The genus name Sanicula is derived from the Latin sano or sanus, meaning "heal" or "whole," and is best translated as "healer"; however, some etymologists have questioned whether this derivation is strictly correct on the principles of classical Latin etymology. Other common names recorded historically include poolroot, wood sanicle, and — confusingly — self-heal, a name it shares with the unrelated Prunella vulgaris.

Sanicula europaea grows to 60 cm high and is glabrous, with coarsely toothed leaves. The pinkish flowers are borne in tight spherical umbels and are followed by bristly fruits which easily attach to clothing or animal fur, facilitating seed dispersal. The leaves are lobed and glossy, dark green. It is widespread in shady places in woodland across Europe.

Taxonomic classification is as follows:

• Kingdom: Plantae
• Order: Apiales
• Family: Apiaceae (Umbelliferae)
• Genus: Sanicula
• Species: S. europaea

Wood sanicle is most abundant in the middle and north of Europe and is also found on the mountains of tropical Africa. It is in flower from May to September, and the seeds ripen from July to September.

It is important to note taxonomic and nomenclatural pitfalls. Care should be taken not to confuse sanicle (Sanicula europaea) with Prunella vulgaris, both of which have been called "self-heal," nor with Astrantia major, which is also sometimes referred to as "sanicle." Sanicle products have been reported to be contaminated with drooping bittercress (Cardamine enneaphyllos) and great masterwort (Astrantia major).

1.1 Plant Parts Used and Common Preparations

The aerial parts (Herba Saniculae) and the underground parts (Radix Saniculae) of Sanicula europaea have been used traditionally in Austrian folk medicine to treat wounds. Traditionally, roots and leaves are harvested: the root in autumn for concentrated compounds, and fresh leaves in spring for poultices.

Common forms and preparations include:

• The plant is typically prepared as a tincture, powder, or decoction for use in herbal medicine. The most common form is a tincture made by soaking the dried roots in alcohol or vinegar. The roots are often ground into a fine powder and used internally or externally.
• Culpeper mentions the use of Sanicle for diseases of the lungs and throat, and recommends the gargle being made from a decoction of the leaves and root in water, with a little honey added.
• Infusions of sanicle, made with water or wine, were commonly used in France to cure dysentery, ulcers, and kidney injuries.

2. Traditional and Historical Use

The name Sanicula comes from sanus, Latin for "healthy," reflecting its use in traditional remedies. Sanicle has traditionally been a favoured ingredient of many herbal remedies, and of it was said "he who has sanicle and self-heal needs neither physician nor surgeon."

Sanicle has been described by Allen & Hatfield (2004) as "an ancient panacea." S. europaea was praised so highly in the old herbals that its folk use raises the strong suspicion that its many (almost universal) uses were entirely derived from the written tradition, being copied, embroidered, and inflated from one herbal to another without any real-world evidence to back up the claims made.

The main claim was that the plant could stop or staunch bleeding from wounds — it was considered a vulnerary. In the Scottish Highlands it was recommended for both bleeding wounds and ulcers, and in the Isle of Man for haemorrhages, dysentery, bruises, and fractures. In Ireland, in County Londonderry, it was applied to cure bleeding piles, while in County Donegal it was used to treat consumption.

Roots of Sanicula europaea have been used in traditional Austrian medicine either internally (as tea) or externally (as an ointment) for the treatment of dermatological diseases, the respiratory tract, the locomotor system, the gastrointestinal tract, and infections. Moreover, the plant was a valued remedy in treating diarrhoea, bleeding, and wounds.

European sanicle has been applied for mild inflammation of the mucous membranes of the respiratory tract. Past external uses in folk medicine included treating wounds and contusions; internally it was used for stomach inflammations and bloody vomiting. The primary application in homeopathy was for diarrhoea.

During the Renaissance, herbal compendia such as Gerard's Herball (1597) documented wood sanicle's astringent properties and recommended it for digestive upsets and sore throats. Historical herbal texts from the Middle Ages and Renaissance often refer to sanicle as a "blood purifier" and a vulnerary herb, used to help heal wounds and stop bleeding. Herbalists believed that sanicle could "cleanse the blood" and promote the healing of internal and external injuries. These uses are documented in works such as Culpeper's Complete Herbal and in traditional folk remedies across Europe.

Sanicle was popularly employed in France and Germany as a remedy for profuse bleeding from the lungs, bowels, and other internal organs, and for checking dysentery, with the fresh juice being given in tablespoonful doses.

Medieval herbalists combined sanicle with other plants in compound preparations. For wounds and trauma, infusions of sanicle were made with water and wine, combined with agrimony and tansy, or decocted in wine together with agrimony, vervain, betony, hyssop, sage, mugwort, and St. John's wort. Sanicle was also used as a gargle in sore throat and quinsy whenever an astringent gargle was required.

In traditional medicine, sanicle was applied to diseases like bronchial catarrh, bleeding from the stomach, and as a remedy for wounds. The drug used was the herb reaped during flowering time.

3. Key Constituents and Active Compounds

S. europaea is characterised by a chemical diversity of biologically active compounds, which underlie its broad spectrum of pharmacological and biological activities. Species of the genus Sanicula contain a wide range of bioactive constituents, including tannins, flavonoids, organic acids, saponins, polysaccharides, coumarins, and essential oils.

Both the underground and aboveground parts of S. europaea accumulate organic acids; triterpenoid saponins (acidic and neutral monodesmosides, saniculosides A, B, C, D); nitrogen-containing compounds; hydroxycinnamic acids; vitamins K and C; flavonoids; tannins, bitter substances; and essential oils.

The rhizomes with roots of S. europaea contain organic acids (malic, citric, malonic, and oxalic), triterpenoid saponins (3.3–5.5%), the nitrogen-containing compound allantoin, as well as hydroxycinnamic acids and their derivatives, including chlorogenic acid (0.8%) and rosmarinic acid (1.4%).

A 2025 study published in Applied Sciences (MDPI) provided detailed phytochemical analysis:

• A total of sixteen phenolic constituents were detected in dry extracts of S. europaea herb and rhizomes with roots. These included one coumarin, four hydroxycinnamic acids, three flavonoids, and eight metabolites derived from tannins. Rosmarinic acid was the most abundant among the hydroxycinnamic acids. Quercetin and apigenin emerged as the leading flavonoids, and epicatechin gallate and gallocatechin were identified as the predominant tannin-related compounds.
• HPLC analysis identified hydroxycinnamic acids (rosmarinic, chlorogenic, neochlorogenic, caffeic, ferulic, p-coumaric), flavonoids (rutin, quercetin), and catechins (halocatechin, epicatechin gallate). The herb is primarily composed of phenolic acids — particularly rosmarinic, chlorogenic, and caffeic — which together account for approximately two-thirds of the total phenolic content. In the rhizomes with roots, the total content of these acids is lower, while the content of catechins is somewhat higher.
• The leaves are characterised by the presence of organic acids (malic, citric, malonic, and oxalic) and triterpenoid saponins (2.8–3.6%), vitamin C, and hydroxycinnamic acids.

3.1 Triterpenoid Saponins

The triterpenoid saponins of Sanicula europaea have been subjects of active isolation chemistry since the 1960s. Barringogenol C and its 16-deoxy derivative were identified from the roots; later, a new triterpene saponin glycoside named saniculoside N (5) was isolated from the aerial parts, and saniculoside R-1 (6) from the leaves.

A new acylated triterpenoid saponin was obtained from the leaves of Sanicula europaea. Its structure was elucidated from NMR and MS data as 21-O-[2-methylbutanoyl]-3β,15α,16α,21β,22α,28-hexahydroxyolean-12-ene 3-O-[α-L-arabinopyranosyl(1→3)]β-D-glucopyranosyl(1→2)-β-D-glucuronopyranoside.

Extracts from the aerial parts of Sanicula europaea were investigated for their anti-HIV activity, and the 50% ethanolic extract was shown to exhibit the highest activity. A new triterpene saponin glycoside, saniculoside N, in addition to the known phenolic acids rosmarinic acid and caffeic acid, were isolated as major components. Rosmarinic acid was established as the principal active substance.

3.2 Phenolic Acids and Flavonoids

Among the identified constituents, epigallocatechin gallate (EGCG), caffeic, chlorogenic and rosmarinic acids, quercetin, apigenin, and kaempferol demonstrated the strongest anti-inflammatory potential.

Phytochemical studies conducted on Saniculeae species indicate that these plants synthesize metabolites belonging to diverse groups of compounds, including triterpenoid saponins, flavonoids, phenolic acids, coumarins, volatile organic compounds, polyacetylenes, ecdysteroids, phytosterols, lignans, betaines, carotenoids, and anthraquinones.

3.3 Allantoin

Among its constituents is allantoin — as found in Symphytum officinale — as well as tannins, saponins, volatile oil, and rosmarinic acid. Allantoin, also found in comfrey, is a well-documented promoter of cell proliferation in wound healing.

4. Mechanisms of Action

4.1 Hemostatic and Astringent Action

The astringent activity of sanicle is attributed principally to its tannin and saponin content. Sanicel herb contains rosmarinic acid (a lamiaceae-type tanning agent), flavonoids, and up to 13% triterpene saponins. According to the German Commission E, Saniculae herba has antibacterial, expectorant, and astringent effects, and has also been found to have an antifungal effect. Tannins exert their hemostatic effect by precipitating surface proteins and contracting blood vessel walls, physically reducing blood flow from wounds.

4.2 Expectorant Action

Sanicle is thought to thin mucus to make it easier to cough up. This expectorant mechanism is consistent with the saponin content of the plant; triterpene saponins are known secretomotor agents that increase respiratory tract secretions and facilitate mucociliary clearance.

4.3 Anti-Inflammatory Action

Among the identified constituents, EGCG, caffeic, chlorogenic and rosmarinic acids, quercetin, apigenin, and kaempferol demonstrated the strongest anti-inflammatory potential in recent screening work. The roots of sanicle have not been extensively investigated, but have been tested in one study by Vogl et al., exhibiting an in vitro anti-inflammatory effect.

4.4 Antiviral Action

Rosmarinic acid, the principal phenolic acid of sanicle, has been studied as an antiviral agent in other plant systems. In a broader mechanistic context, it has been shown to act on multiple pathways involved in viral replication. The antiviral action of S. europaea extracts is attributed to the acidic fraction of leaf extracts, suggesting a role for the phenolic acid complex rather than any single isolated molecule.

5. Scientific Evidence by Area of Use

5.1 Wound Healing and Hemostasis

Sanicula europaea has long been used in traditional medicine as a hemostatic agent, for accelerating wound healing, and for treating inflammatory and dermatological conditions; however, scientific evidence supporting these uses has remained limited.

The most comprehensive pharmacological study to date was published in Applied Sciences (November 2025). Comprehensive phytochemical and pharmacological screening of aqueous and hydroethanolic extracts from the herb and rhizomes with roots was performed. Hemostatic properties were assessed using the Duke bleeding time method, and the herb extracts significantly reduced bleeding time. The use of herb extracts also accelerated wound healing.

Based on the results of pharmacological screening, herb extracts of S. europaea demonstrated pronounced hemostatic, wound-healing, anti-inflammatory, and antimicrobial activities. The authors noted that future studies should focus on expanding the experimental model and conducting clinical trials to assess safety, optimal dosage, and long-term efficacy.

Both aerial and underground parts of Sanicula europaea showed similar chemical compositions — hydroxycinnamic acid derivatives and triterpene saponins — findings that suggest the same wound-healing activity for the underground parts as was already found for the aerial parts.

In an in vitro cell assay using 3T3 fibroblasts, an extract of the herb of sanicle showed no enhancement of wound closure, but it was revealed to be beneficial as an antibiotic and debridement-boosting agent. This is an important qualification: the fibroblast scratch assay did not demonstrate direct stimulation of cell migration, but antimicrobial and anti-inflammatory properties may support wound healing through secondary mechanisms.

Evidence strength: Preclinical (animal models and in vitro cell assays). No randomised controlled trials in humans have been published to date. The evidence is preliminary but mechanistically plausible.

5.2 Antimicrobial Activity

Both herb and rhizome-root extracts of S. europaea exhibited inhibitory effects against Pseudomonas aeruginosa, Escherichia coli, Proteus vulgaris, Staphylococcus aureus, and Staphylococcus epidermidis in the agar diffusion method with paper discs.

S. europaea is known to possess antimicrobial as well as anti-inflammatory effects, which may contribute to an overall wound-healing activity.

Evidence strength: In vitro laboratory studies only. No clinical antimicrobial trials have been conducted. Results are consistent across multiple laboratory groups but have not been validated in human infection models.

5.3 Antiviral Activity

Several in vitro studies, conducted primarily by Turkish research groups in the 1990s, investigated the antiviral potential of S. europaea extracts:

• The antiviral activity of S. europaea extracts against human parainfluenza virus type 2 (HPIV-2) was examined. The extract prepared from the leaves of the plant and a fraction separated from the crude extract with gel filtration chromatography were found to inhibit HPIV-2 replication without any toxic effect on Vero cells. The acidic fraction was found to be the most active fraction at non-cytotoxic concentrations. Unfortunately, antiviral activity was not detected in the molecules purified from the crude ethanol extract of sanicle leaves. (Karagöz et al., Phytotherapy Research, 1999)
• Fractions I, II, and III separated from sanicle extract with Sephadex column chromatography were found to be non-toxic against MDCK cells. The growth of influenza A/PR/8/34 was completely inhibited by these fractions, while that of influenza B/Lee/40 was not affected. (Turan et al., Biochemical and Biophysical Research Communications, 1996)
• Extracts from the aerial parts of S. europaea were investigated for their anti-HIV activity, and the 50% ethanolic extract was shown to exhibit the highest activity. Saniculoside N, rosmarinic acid, and caffeic acid were isolated as major components. Rosmarinic acid was established as the principal active substance. (Arda et al., Journal of Natural Products, 1997)

Evidence strength: All antiviral evidence is in vitro only, from cell-culture models. No human clinical trials have been conducted. The selectivity of antiviral activity — inhibiting influenza A but not influenza B, for example — indicates that results cannot be generalised across virus types. Evidence is preliminary.

5.4 Respiratory Tract Conditions (Expectorant / Bronchitis)

Sanicel herb is used for mild catarrh of the airways (bronchitis). The daily dose of the drug is 4 to 6 g. No known adverse effects have been recorded at this dose.

The German Commission E monographs approved the use of S. europaea as a mild astringent and an expectorant. European sanicle is applied for mild inflammation of the mucous membranes of the respiratory tract.

Evidence strength: The Commission E approval for mild upper respiratory catarrh represents the highest regulatory-level recognition for this plant; however, the Commission E approval was based on traditional use and general pharmacological rationale rather than on controlled clinical trials. No randomised controlled human trials specifically evaluating sanicle as an expectorant have been published.

5.5 Anti-inflammatory Activity

Based on the results of phytochemical analysis and pharmacological screening, herb extracts of Sanicula europaea demonstrated pronounced anti-inflammatory activities and may be used for the development of novel plant-based medicinal products.

The pharmacological potential of Saniculeae species includes antioxidant, anti-inflammatory, antimicrobial, antiviral, antiprotozoal, antitumour, antidiabetic, hypocholesterolaemic, and neuroprotective activities, as reviewed in Phytochemistry Reviews (Springer, 2024). These remain, however, areas of ongoing basic research rather than established clinical applications.

Evidence strength: Preclinical (in vitro and animal models). No human trials for inflammatory conditions specifically.

6. Body Systems and Health Areas Associated with Sanicle

Based on traditional use and laboratory pharmacology, the following body systems are associated with S. europaea:

• Skin and wound-healing system: Sanicle was used in Europe for healing wounds and cleaning. Laboratory data support hemostatic and antimicrobial actions relevant to dermal wound care.
• Respiratory system: European sanicle is traditionally used in herbal medicine for its therapeutic properties, particularly in treating respiratory and digestive ailments, and has been historically applied to alleviate symptoms of coughs, bronchitis, and other respiratory conditions. The German Commission E sanctioned its use for mild upper respiratory catarrh.
• Gastrointestinal system: Past external uses in folk medicine included treating wounds and contusions, and European sanicle was used internally for stomach inflammations and bloody vomiting.
• Haematological system (haemostasis): The plant's primary historic and pharmacologically-supported role is as a haemostatic agent, reducing bleeding time in preclinical models.
• Immune / antiviral system: Filtered leaf extracts of Sanicula europaea have shown some antiviral properties, inhibiting the replication of type 2 human parainfluenza viruses (HPIV-2).

7. Dosage Forms and Reported Dosages

The following dosages and forms appear in published or referenced sources:

• Dried herb (internal, Commission E-referenced): The daily dose of the drug is 4 to 6 g.
• Infusion/tea: Roots of S. europaea have been used internally as tea. Specific preparation ratios are not standardised in any current pharmacopoeia.
• Topical ointment: Sanicle is used externally as an ointment in Austrian folk medicine tradition.
• Tincture (reported in traditional sources): The plant is typically prepared as a tincture, made by soaking the dried roots in alcohol or vinegar.
• Fresh juice (historical French/German practice): Sanicle was popularly employed in France and Germany, with the fresh juice being given in tablespoonful doses.

No standardised dosages for human clinical use have been established from controlled clinical trials. The Commission E daily dose of 4–6 g of dried herb is the only regulatory-body dosage guidance identified in the literature.

8. Safety Considerations

8.1 General Safety Profile

No health hazards or side effects are known concerning the proper administration of designated therapeutic dosages. When taken by mouth, sanicle is possibly safe for most people. In large amounts, it may cause side effects including stomach upset, nausea, and vomiting.

8.2 Known Adverse Effects

Allergic reactions to the plant have been noted. There are no known interactions with other substances. The saponin content of the plant is relevant to gastrointestinal tolerance: leaves and young shoots contain saponins and should not be eaten in large quantities.

8.3 Adulteration and Misidentification

In the Austrian vernacular, "Radix Saniculae" can also refer to the underground parts of Cardamine enneaphyllos. This ambiguity can lead to mistakes in using these two plants and, importantly, adulterations. Sanicle products have been reported to be contaminated with drooping bittercress (Cardamine enneaphyllos) and great masterwort (Astrantia major). Analytical methods including TLC, HPLC-DAD, UHPLC-ESI-MS, and GC-MS have been demonstrated to allow identification of such adulterations.

8.4 Interactions

Sanicle may have additive effects when taken with antifungal, antioxidant, antiviral, diuretic, and blood pressure-lowering herbs and supplements. Sanicle may also add to the effects of herbs or supplements that thin mucus. These potential interactions are based on the known pharmacological activities of sanicle's constituents and are not derived from human pharmacokinetic interaction studies.

8.5 Sustainability

The European sanicle is increasingly harvested for its medicinal properties, raising concerns about its sustainability in the wild. Wild harvesting can lead to overexploitation, especially in regions where the plant is already rare or habitat-specific. Its limited distribution and slow growth rate make it particularly vulnerable to population decline.

9. Evidence Summary and Current Status

Sanicle (Sanicula europaea) occupies a well-documented place in European ethnobotany with a use history spanning medieval and early modern periods across Britain, France, Germany, Austria, Ireland, and Scotland. The German Commission E monographs approved the use of S. europaea as a mild astringent and an expectorant. This remains the sole regulatory approval for the plant in the Western world.

At the scientific level, the overall body of evidence is characterised by:

• A well-characterised phytochemical profile, with triterpenoid saponins, rosmarinic acid, flavonoids, and tannins as the principal bioactive compound classes.
• Preclinical (in vitro and animal model) evidence supporting hemostatic, wound-healing, antimicrobial, anti-inflammatory, and antiviral activities.
• An absence of published randomised controlled trials in human populations for any indication.
• Scientific evidence supporting the traditional uses of S. europaea remains limited.
• Future studies should focus on expanding experimental models and conducting clinical trials to assess safety, optimal dosage, and long-term efficacy.

The gap between the extensive traditional reputation of sanicle and the current state of clinical research is considerable. The plant's pharmacological profile — particularly its rosmarinic acid content, triterpenoid saponins, and tannins — provides a plausible mechanistic basis for several of its traditional applications, but this has not yet been validated in human trials.

References

• Sanicula europaea L. Herb and Rhizomes with Root Extracts with Hemostatic, Wound Healing, Anti-Inflammatory and Antimicrobial Activity: Phytochemical and Pharmacological Research — Applied Sciences (MDPI), 2025
• "Radix Saniculae": Phytochemical Characterization and Potential Adulteration of an Austrian Traditional Wound-Healing Agent — PMC/NCBI, 2025
• Arda N et al. Saniculoside N from Sanicula europaea L. — Journal of Natural Products, 1997 (PubMed)
• Schöpke T et al. Saniculoside R-1: a new triterpenoid saponin from Sanicula europaea — Planta Medica, 1998 (PubMed)
• Karagöz A et al. Antiviral activity of Sanicula europaea L. extracts on multiplication of human parainfluenza virus type 2 — Phytotherapy Research, 1999 (PubMed)
• Little-known Saniculeae genera: phytochemical studies and pharmaceutical activities — Phytochemistry Reviews, Springer Nature, 2024
• Hiller K. Sanicula europaea L. — Sanikel. Zeitschrift für Phytotherapie (Thieme), 2005
• Wound Healing Plants in Austrian Folk Medicine — Thieme, 2024
• Sanicula europaea — Wikipedia
• Saniculae herba — Altmeyer's Encyclopedia (Phytotherapy), referencing Commission E
• Sanicle — Scientific Monograph (Efficacy.pro / Natural Standard)
• Sanicula europaea L. — Botanical Society of Britain and Ireland (BSBI)
• Sanicula europaea L. — Sanikel (ResearchGate / Thieme)
• Sanicula europaea — Plants For A Future (PFAF)
• Sanicula, Sanicle — Medicine Traditions